SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

12 Months Ended

Dec. 31, 2014

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION [Abstract]

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

NOTE 11 - SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION

Balance sheets:

a. Accounts receivable:

	December 31,
	2014			2013
	($ in thousands)
1) Trade:
Open accounts	$	972		$	2,260
Allowance for doubtful accounts		(337	)		(405	)
	$	635		$	1,855
2)  Other:
Due from government institutions	$	162		$	221
Advance payments to suppliers		180			152
Miscellaneous		17			14
	$	359		$	387

The changes in “Allowance for doubtful accounts” during the year ended December 31, 2014, the six month period ended December 31, 2013, as well as the years ended June 30, 2013 and 2012 are as follows:

				6 month		Year ended
	Year ended			period ended		June 30,
	December 31, 2014			December 31, 2013		2013			2012
	($ in thousands)
Balance at beginning of period	$	405		$	329	$	215		$	155
Additions during the period		35			58		245			78
Deductions during the period		(57	)				(142	)
Exchange rate differences		(46	)		18		11			(18	)
Balance at end of period	$	337		$	405	$	329		$	215

b. Inventories:

	December 31,
	2014		2013
	($ in thousands)
Finished goods		1,273	$	1,097
Work in process		326		341
Raw materials and supplies		325		155
		1,924	$	1,593

For the year ended December 31, 2014, as well as December 31, 2013 and June 30, 2013 and 2012 the Company recorded expenses for slow moving inventory in the amounts of $129,000, $40,000, $0 and $443,000, respectively.  

c. Accounts payable and accruals-other:

	December 31,
	2014		2013
	($ in thousands)
Employees and employee institutions	$	1,022	$	1,133
Accrued vacation and recreation pay		410		325
Accrued clinical trials expenses		1,016		622
Provision for sales commissions		120		139
Accrued expenses		993		886
Taxes payable		15		36
	$	3,576	$	3,141

Statements of Operation:

d. Financial expenses, net:

	Year ended December 31,			6 month period ended			Year ended June 30,
	2014			December 31, 2013			2013			2012
	($ in thousands)
Bank commissions	$	43		$	27		$	38		$	50
Interest income		(2	)		(2	)		(28	)		(40	)
Exchange rate differences		(18	)		1			(63	)		112
Induced conversion of convertible debt								9,330
Issuance of warrants								568
Interest expense (including amortization of debt issuance costs)		1,409			273			4,268			1,238
Change in fair value of warrants, embedded derivatives and anti-dilution rights		(47	)		200			64			(1,322	)
	$	1,385		$	499		$	14,177		$	38